Generation Bio
在场
是其中之一......
Generation Bio 是一家在股票代码 GBIO (US) 下上市的公司。
涉及Generation Bio的并购和融资。
- Generation Bio 刚刚宣布为 76 筹款数百万美元。 (公布2023三月28号).
高管
查看带有其 16 名主要高管的组织结构图
Generation Bio 搜索最多的简介
- Geoff McDonough, Director, President and Chief Executive Officer
- Jason Rhodes, Chairman of the Board
- Catherine Stehman-Breen, Director
创建提醒
跟踪 Generation Bio 的高管变动
生物技术
Generation Bio 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
- TuHura Biosciences and Kintara Therapeutics have merged (公布2024十月20号)..
生物技术 行业的其他推荐联系人
消息
Generation Bio 的最新新闻稿
- Generation Bio to Present at the 2024 Cantor Global Healthcare Conference - Generation Bio
- Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit - Generation Bio
- Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results - Generation Bio
- Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting - Generation Bio
- Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting - Generation Bio
- Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference - Generation Bio
- Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference - Generation Bio
- Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results - Generation Bio
- Generation Bio to Present at the 2024 TD Cowen Health Care Conference - Generation Bio
- Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms - Generation Bio
- View more press releases Close
通过电子邮件
